Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide with radiotherapy for newly diagnosed diffuse pontine glioma
2007-001768-60Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Mar 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in diffuse intrinsic pontine glioma (DIPG) and brainstem glioma, sponsored by University of Birmingham. Primary endpoints: Median survival to death, Median time to tumor progression and 5 more. Started Mar 2008; status: completed.
02
Drugs
temozolomide
03
Conditions
diffuse intrinsic pontine glioma (DIPG)brainstem glioma
Beyond the preview
Go deeper on 2007-001768-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001768-60.